Close
CDMO Safety Testing 2026
Novotech

Innovacyn introduces eye, ear formulations

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Firefly Bio Acquisition Strengthens J&J Cancer Pipeline

Johnson & Johnson (J&J) has entered into a definitive...

Sanofi and Owkin Partner to Co-Develop Agentic AI Tools for Drug Discovery

Sanofi has entered into a multi-year agreement with France-based...

Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement

The Pfizer Innovent Cancer Deal has been finalized, establishing...
- Advertisement -

Innovacyn, a provider of human and animal healthcare products, has added Vetericyn VF Ophthalmic Wash and Vetericyn VF Otic Rinse to its professional-strength animal healthcare line.

The antimicrobial solution found in the Ophthalmic Wash and Otic Rinse inhibits antibiotic-resistant strains of bacteria (including staph and MRSA) as well as fungi, viruses and spores.

Innovacyn claims Ophthalmic Wash and Otic Rinse are steroid-free, antibiotic-free and contain no alcohol or iodine and consists of oxychlorine compounds similar to those produced by the animal’s own immune system.

The Vetericyn VF Ophthalmic Wash is a twist-top that cleans wounds, eliminates the eye infections caused by viruses or fungi, and inhibits bacteria.

It also works as a no-rinse flush to relieve irritated eyes, or debride eye abrasions and wounds in the surrounding area of the eye.

The Vetericyn VF Otic Rinse inhibits infections, cleans wounds, and speeds the healing process in the outer ear and ear canal and also eliminates skin irritation.

ย 

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Firefly Bio Acquisition Strengthens J&J Cancer Pipeline

Johnson & Johnson (J&J) has entered into a definitive...

Sanofi and Owkin Partner to Co-Develop Agentic AI Tools for Drug Discovery

Sanofi has entered into a multi-year agreement with France-based...

Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement

The Pfizer Innovent Cancer Deal has been finalized, establishing...

Transforming the Future of Pharmaceutical Innovation

The pharmaceutical industry stands at the edge of a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป